The largest database of trusted experimental protocols

Human mixed genomic dna

Manufactured by Promega

Human mixed genomic DNA is a DNA sample obtained from a pool of human individuals. It is a complex mixture of genomic DNA representing the genetic diversity of the human population. This product is suitable for use as a reference or control material in various genomic and genetic analysis applications.

Automatically generated - may contain errors

3 protocols using human mixed genomic dna

1

Validation of Fusion Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR and Sanger sequencing confirmed the presence of fusion candidates generated by Trellis. Primers were designed 200 bp on either side of the junction (Table S1m). Primerswere purchased from IDT (Coralville, IA) and purified by desalting. Primers and probes were resuspended to 100 μΜ in IDTE (10 mM Tris, pH 8.0; 0.1 mM EDTA) buffer and stored at − 20° C. Using the primers specific for each fusion, PCR amplification was performed in a 50-μL reaction volume in quadruplicate, consisting of 10 μL of 5X Phusion buffer, 1 μL of 10 mM dNTP, 2.5 mL of each primer at 10 mM, 0.5 μL of HotStart Phusion, and 10 ng of cell line DNA. PCR was performed using a Bio-Rad S1000 Thermal Cycler. The thermal cycle was programmed for 30 s at 98° C for initial denaturation, followed by 34 cycles of 10 s at 98°C for denaturation, 30 s at 59°C for annealing, 30 s at 72°C for extension, and 5 min at 72°C for final extension. Human mixed genomic DNA (Promega, Madison, WI) and no template were used as negative controls. PCR products were purified using Nucleospin Gel and PCR cleanup as per the manufacturer’s instructions (Macherey-Nagel, Duren, Germany). PCR products were then subjected to Sanger sequencing using the Applied Biosystems 3730xl DNA Analyzer as per manufacturer’s instructions (Thermo Fisher, Waltham, MA). Output was compared to original candidate fusion sequence and confirmed.
+ Open protocol
+ Expand
2

Profiling Diffuse Large B-cell Lymphoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
22 adult patients with de novo CD20+ Diffuse Large B-cell Lymphoma (DLBCL) or primary mediastinal B-cell lymphoma (PMBL) were selected from the prospective, multicenter, and randomized LNH-03B LYSA trials with available frozen tumor samples and adequate DNA quality. CGH was previously performed for these samples after whole-genome amplification against a Promega normal DNA pool using Agilent SurePrint G3 4×180  K microarrays. Briefly, arrays were scanned with Agilent Feature Extraction and processed with cghRA pipeline as previously described [12 (link)].
DNA from REC-1 cell line, established from the lymph node of a 61-year-old man with refractory B-cell lymphoma, was extracted. Dilutions at 50%, 30%, 20%, 10% and 5% of this DNA were performed using Human Mixed Genomic DNA Promega. Human Genomic DNA comes from multiple anonymous donors.
Five blood samples of healthy individuals were collected and used as a control to construct the pseudo-reference profile.
+ Open protocol
+ Expand
3

Validation of Fusion Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
PCR and Sanger sequencing confirmed the presence of fusion candidates generated by Trellis. Primers were designed 200 bp on either side of the junction (Table S1m). Primerswere purchased from IDT (Coralville, IA) and purified by desalting. Primers and probes were resuspended to 100 μΜ in IDTE (10 mM Tris, pH 8.0; 0.1 mM EDTA) buffer and stored at − 20° C. Using the primers specific for each fusion, PCR amplification was performed in a 50-μL reaction volume in quadruplicate, consisting of 10 μL of 5X Phusion buffer, 1 μL of 10 mM dNTP, 2.5 mL of each primer at 10 mM, 0.5 μL of HotStart Phusion, and 10 ng of cell line DNA. PCR was performed using a Bio-Rad S1000 Thermal Cycler. The thermal cycle was programmed for 30 s at 98° C for initial denaturation, followed by 34 cycles of 10 s at 98°C for denaturation, 30 s at 59°C for annealing, 30 s at 72°C for extension, and 5 min at 72°C for final extension. Human mixed genomic DNA (Promega, Madison, WI) and no template were used as negative controls. PCR products were purified using Nucleospin Gel and PCR cleanup as per the manufacturer’s instructions (Macherey-Nagel, Duren, Germany). PCR products were then subjected to Sanger sequencing using the Applied Biosystems 3730xl DNA Analyzer as per manufacturer’s instructions (Thermo Fisher, Waltham, MA). Output was compared to original candidate fusion sequence and confirmed.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!